Acambis PLC Successfully Delivers On ACAM2000 Smallpox Vaccine Order To US Government – Expects To Meet 2006 Revenue Guidance

Cambridge, UK and Cambridge, Massachusetts – 8 January 2007 – Acambis plc (Acambis) (LSE: ACM) announces that it successfully delivered 10 million doses of ACAM2000 smallpox vaccine to the US Centers for Disease Control and Prevention (CDC) in December 2006, generating revenue of approximately £16m, which will be recognised in the last quarter of 2006. Acambis will receive payment in early 2007 and expects to meet its 2006 revenue guidance of around £30m.

Back to news